Axogen, Inc. — Director's Dealing 2020

Jun 1, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2020-05-29

Reporting Person: Freitag Gregory Gene (Director, General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-29	Common Stock	M	125000	$3.50	Acquired	231484	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-29	Employee Stock Option (right to buy)	$3.5	M	125000	Disposed	2020-06-01	Common Stock (125000)	Direct

Footnotes

F1: 1. This Form is being filed to report the cash exercise of a stock option for a total of 125,000 shares.